Original languageEnglish (US)
Pages (from-to)1-2
Number of pages2
JournalTargeted Oncology
Volume4
Issue number1
DOIs
StatePublished - Jan 1 2009

Fingerprint

Drug Pulse Therapy
Piperazines
bcr-abl Fusion Proteins
CD Antigens
Boronic Acids
Neoplasm Antibodies
Pyrazines
Pyrimidines
Drug Design
Neoplasm Antigens
Hematologic Neoplasms
Proteasome Endopeptidase Complex
Combination Drug Therapy
Biomedical Research
Glycoproteins
Monoclonal Antibodies
Therapeutics

ASJC Scopus subject areas

  • Oncology
  • Cancer Research
  • Pharmacology (medical)

Cite this

Targeted therapy and hematological malignancy. / Armitage, James Olen.

In: Targeted Oncology, Vol. 4, No. 1, 01.01.2009, p. 1-2.

Research output: Contribution to journalEditorial

@article{3d9b4e69b90c4a93801cb76795c91824,
title = "Targeted therapy and hematological malignancy",
author = "Armitage, {James Olen}",
year = "2009",
month = "1",
day = "1",
doi = "10.1007/s11523-008-0098-1",
language = "English (US)",
volume = "4",
pages = "1--2",
journal = "Targeted Oncology",
issn = "1776-2596",
publisher = "Springer Paris",
number = "1",

}

TY - JOUR

T1 - Targeted therapy and hematological malignancy

AU - Armitage, James Olen

PY - 2009/1/1

Y1 - 2009/1/1

UR - http://www.scopus.com/inward/record.url?scp=59849102863&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=59849102863&partnerID=8YFLogxK

U2 - 10.1007/s11523-008-0098-1

DO - 10.1007/s11523-008-0098-1

M3 - Editorial

C2 - 19343296

AN - SCOPUS:59849102863

VL - 4

SP - 1

EP - 2

JO - Targeted Oncology

JF - Targeted Oncology

SN - 1776-2596

IS - 1

ER -